Polysaccharides extracted from the roots of Bupleurum chinense DC modulates macrophage functions

Polysaccharides extracted from the roots of Bupleurum chinense DC modulates macrophage functions

Chinese Journal of Natural Medicines 2017, 15(12): 08890898 Chinese Journal of Natural Medicines •Research Articles• Polysaccharides extracted fro...

1MB Sizes 0 Downloads 35 Views

Chinese Journal of Natural Medicines 2017, 15(12): 08890898

Chinese Journal of Natural Medicines

•Research Articles•

Polysaccharides extracted from the roots of Bupleurum chinense DC modulates macrophage functions ZHANG Zhi-De1Δ, LI Hong1Δ, WAN Fen1, SU Xiao-Yu1, LU Yan2, CHEN Dao-Feng2 *, ZHANG Yun-Yi1 * 1

Department of Pharmacology, School of Pharmacy, Fudan University; Shanghai 201203, China; Department of Pharmacognosy, School of Pharmacy, Fudan University; Shanghai201203, China

2

Available online 20 Dec., 2017

[ABSTRACT] The present study aimed to investigate the effects of polysaccharides extracted from Bupleurum chinense DC (BCPs) on macrophage functions. In the in vivo experiment, 1 mL of 5% sodium thioglycollate was injected into the abdomen of the mice on Day 0 and macrophages were harvested on Day 4. The macrophages were cultured in plates and treated with different concentrations of BCPs and stimulus. Effects of BCPs on macrophage functions were assessed by chemotaxis assay, phagocytosis assay and Enzyme-Linked Immunosorbent Assay (ELISA). Our results showed the enhanced chemotaxis, phagocytosis and secretion of nitric oxide (NO) and inflammatory cytokines by macrophages when treated with BCPs. However, when chemotaxis and phagocytosis were up-regulated by complement components or opsonized particles, BCPs inhibited these effects. Also, the NO production induced by lipopolysaccharides (LPS) was suppressed by BCPs mildly. Moreover, BCPs had an inhibitory effect on the [Ca2+]i elevation of macrophages. These results suggested that BCPs exerted modulatory effects on macrophage functions, which may contribute to developing novel approaches to treating inflammatory diseases. [KEY WORDS] Bupleurum chinense DC; Polysaccharides; Macrophage functions; [Ca2+]i

[CLC Number] R965

[Document code] A

[Article ID] 2095-6975(2017)12-0889-10

Introduction Bupleurum spp. is a traditional Chinese medicine with proven anti-inflammatory, antipyretic, analgesic and immunomodulatory activities [1-3]. Previous researchers have extracted polysaccharides from Bupleurum smithii, which have proven effective against autoimmune disease [4-5] such as systemic lupus erythematosus [2]. Compared with polysaccharides extracted from Bupleurum smithii (BPs), polysaccha[Received on] 17- Dec.-2016 [Research funding] This work was supported by the National Natural Science Foundation of China (Nos. 30925042, 81274165, and 81330089), the State Key Program for New Drugs from the Ministry of Science and Technology, China (No. 2012ZX09301001-003), and the Science and Technology Commission of Shanghai Municipality (Nos. 10XD1405900 and 12JC1400800). [*Corresponding author] Tel: 86-021-51980050 (Zhang Yun-Yi); 86-021-51980135 (Chen Dao-feng); E-mails: [email protected] (Chen Dao-feng); [email protected] (Zhang Yun-Yi). Δ

These authors contributed equally to this work. These authors have no conflict of interest to declare. Published by Elsevier B.V. All rights reserved

rides extracted from Bupleurum chinense DC (BCPs) have distinct compositional differences [6-7], while both were found having high anti-complementary activity and inhibiting inflammation in animal models [8-9]. In a previous study, we have observed that BCPs attenuate inflammatory cells aggregation in the bronchoalveolar lavage fluid and prevent TNF-α and NO over-production. BCPs also significantly attenuate lung injury with improved lung morphology in LPS-induced acute lung injury mice, in which macrophages play an important role [8]. Inflammation is a complex process mediated by a variety of signaling molecules and cells. When inflammation happens, monocytes/macrophages and neutrophils accumulate at infection sites to kill pathogens. Macrophages are major inflammatory and immune system cells. Activated macrophages are present in inflamed tissues and produce a variety of pro-inflammatory mediators, such as cytokines [interleukin 1(IL-1), tumor necrosis factor α (TNF-α), chemotactic factors, adherence factors (monocyte chemo-attractant protein 1 (MCP-1), IL-8), and cytotoxic mediators (nitric oxide (NO), reactive oxygen species (ROS))] [10-11]. Macrophages also clear pathogens and apoptotic cells by phagocytosis, which is

– 889 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

mediated by receptors on the membrane [12]. Free Ca2+ in immune cells help modulate inflammatory response [13]. In macrophages, low free cytosolic Ca2+ is found to play a regulatory role in inducible nitrous oxide synthase (iNOS) reaction [14]. Lipopolysaccharide (LPS) treatment has been proven to increase intracellular calcium concentration ([Ca2+]i) which is related to the release of the cytokine, TNF-α [15]. Blocking calcium influx could modulate both LPS and interferon-γ (IFN-γ) inflammatory responses, including proinflammatory cytokines secretion and phagocytic activity [16]. Presently, the mechanisms of BCPs’ function in inflammation remain unclear. Based on the above-mentioned studies and macrophage roles in inflammatory diseases, we investigated the effects of BCPs on macrophage functions, including chemotaxis, phagocytosis, cytokine production and intracellular Ca2+ fluctuation.

Materials and Methods Animals Male Balb/c mice and Kunming mice (6-8-weeks-old) were purchased from Slac Laboratory Animal Corporation (Shanghai, China) and housed under specific pathogen free (SPF) conditions, with a 12 h/12 h light/dark cycle, while accessing to tap water and food ad libitum. All the experimental protocols described in the present study were approved by the Animal Ethics Committee of the School of Pharmacy, Fudan University (approval Number: 2013-53, approved on 15th Oct., 2013). Isolation and purification of BCPs Bupleurum chinense DC polysaccharides (BCPs) were isolated at the pharmaceutical chemistry laboratory of Dr. Chen Dao-Feng (Fudan University, Shanghai, China). Identification of Bupleurum chinense DC and methods for isolating polysaccharides have been previously reported [8]. Briefly, the dried roots were ground into fine particles and defatted using 95% EtOH, and the residues were then dried in the shade and extracted with hot water. The supernatant was extensively dialyzed against running water and precipitated by adding 4 volumes of 95% EtOH. After centrifugation, the precipitate was washed with anhydrous EtOH and then lyophilized to produce the crude polysaccharide (BCPs). Chemicals and Reagents LPS (from Escherichia coli O111: B4), fluorescein isothiocyanate-conjugated Staphylococcus aureus (FITC-conjugated S. aureus), and dexamethasone (DEX) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Fluo-3 AM ester was provided by Invitrogen (Carlsbad, CA, USA). Fetal calf serum (FCS) was purchased from Gibco Inc (CA, USA). ELISA assay kits for mouse TNF-α, IL-6, IL-1β, and IL-12 were purchased from Boatman Corp. (Shanghai, China). Recombinant human complement components C3a and C5a were purchased from R&D Corp. (Minneapolis, MN, USA). RPMI 1640 medium was purchased from Hyclone (Logan, UT, USA). Complement-activated product was prepared by our lab and

added into cell culture plates according to protocols below. Preparation of complement-activated product (CAP) began with washing fresh sheep blood cells in sterile saline and centrifuging them at 800 g. The procedure was repeated thrice to obtain packed sheep red blood cells, subsequently diluting these with sterile saline (V/V) to 2% sheep red blood cells (2%-SRBC). Next, equal volumes 2%-SRBC and rabbit anti-SRBC IgG (1 : 1 000 dilution) were mixed, then incubated in a water bath at 37 ºC for 30 min. Once centrifuged at 734 g and 4 ºC for 10 min, the sediment was mixed with serum from guinea pigs, which was bathed at 37 ºC for 30 min, so that the red blood cells completely dissolved. After centrifuging again under the same conditions, the supernatants, now considered as complement-activated product, were collected and stored at –20 ºC until experiments. Macrophage Isolation and Culture Peritoneal macrophages were isolated as previously described, with minor modifications [17]. Briefly, 1 mL of 5% sodium thioglycollate was injected into to the abdomen of the BALB/c mice on Day 0. On Day 4, the animals were euthanized. About 5 mL of cold RPMI 1640 serum-free medium, containing 100 U·mL−1 of penicillin and 100 μg·mL−1 of streptomycin, was injected into the abdomen. The reacted RPMI 1640 medium was then drawn back and centrifuged at 80 g for 10 min. After discarding the supernatant, the cells were re-suspended and plated on 48-well plates at a density of 1 × 106 cells per well in RPMI 1640 medium with 10% (V/V) FCS. Once cultured for 2 h in moist air at 37 ºC and with 5% CO2, the cells were washed twice with the medium and then reserved for the following experiments. In all experiments, macrophages incubated in RPMI 1640 medium with 10% (V/V) FCS alone were considered the control group, while those treated with CAP, C3a, C5a, and LPS were considered the model group. Those cells treated with DEX were used as the positive control. RAW264.7 macrophage cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI 1640 medium with 10% (V/V) fetal bovine serum (FBS) , 100 U·mL−1 penicillin, and 100 μg·mL−1 streptomycin, at 37 ºC in a humidified, 5% CO2 incubator. The cells were then used for the intracellular calcium assay. Assay on macrophages chemotaxis Chemotaxis assay was conducted using trans-well migration assay [18], with some modifications. For the test investigating the effects of BCPs on chemotaxis, macrophages were plated at a density of 1 × 106 cells per well in the upper compartment. BCPs (100 μL) at final concentrations of 10, 20, 40, and 80 μg·mL−1 or 100 μL of DEX (10 μmol·L−1) was added to the lower compartment. Then the trans-well plate was incubated in a humidified, 5% CO2 incubator for 4 h, whereupon the chambers were washed twice with PBS to remove non-migrated macrophages. Chemo-attracted macrophages on the lower surface of the microporous membrane were fixed by exposure to 3% glutaraldehyde for 30 min at room tempera-

– 890 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

ture, stained with Wright-Giemsa pigment, and finally observed by light microscopy at 400 × magnification. 10 views were photographed in each well and the number of cells per view was counted. For the test that explored the effects of BCPs on chemotaxis under complement components stimulation, macrophages were plated at a density of 1 × 106 cells per well in the upper compartment. After chemotactic factor (100 μL of CAP, 500 ng·mL−1 of C3a, or 50 ng·mL−1 of C5a) had been added to the lower compartment, either 100 μL of DEX (10 μmol·L−1), or 100 μL of BCPs at final concentrations of 10, 20, 40, and 80 μg·mL−1 was also added. The subsequent steps were exactly the same as mentioned above. Assay of macrophage phagocytosis The phagocytic experiments conducted were similar to those reported previously [2], for which macrophages were plated at a density of 2 × 105 cells per well in 48-well culture plates and incubated for 1 h. Then, the wells were washed thrice to remove non-adhering cells, while the adherent cells were reserved for further study. Phagocytosis assay of IgG-opsonized sheep red blood cells (SRBCs) IgG-opsonized SRBCs (IgG-SRBCs) were prepared by incubating sheep red blood cells with a 1 : 4 000 dilution of rabbit anti-SRBC IgG for 30min at 37 ºC. Centrifuging the mixture at 734 g and 4 ºC for 10 min preceded retention and re-suspension, sediment to be used as IgG-opsonized SRBC. After 100 μL of IgG-opsonized SRBCs was added to the wells, either 100 μL of DEX (10 μmol·L−1) or 100 μL of BCPs at final concentrations of 10, 20, 40, and 80 μg·mL−1, was added gently to the 24-well plates and co-incubated with macrophages for another 30 min. Then, the 24-well plates were washed with PBS to remove non-engulfed SRBCs. Finally, macrophages were fixed for 50 min with 99.9% methanol and stained with Wright-Giemsa pigment. The phagocytic index and phagocytic rate were defined as follows: phagocytic rate = number of macrophages that engulfed SRBCs out of 100 macrophages, phagocytic index = number of internalized SRBCs in 100 macrophages. Phagocytosis assay of CRBCs treated with/without complement activation product (CAP) CRBCs were washed thrice with saline and diluted at 1: 50 with 10% FCS-1640 to form 2% CRBCs, which was added to the 48-well plates. Then 100 μL of DEX (10 μmol·L−1) or 100 μL of BCPs at final concentrations of 10, 20, 40, and 80 μg·mL−1, was added gently to the 48-well plates and co-incubated with macrophages for 1 h. After, the plates were washed thoroughly to remove non-engulfed CRBCs, and then macrophages were fixed with 99.9% methanol and marked with Wright-Giemsa staining. In the assay of phagocytosis of CRBCs opsonized with CAP, 2% CRBCs, prepared as mentioned above, were next exposed to complement-activated product V/V = 1: 1) at 30 ºC for 30 min. After centrifugation, the CAP-treated CRBCs

were collected and re-suspended in 10% FCS-1640 (V/V = 1: 50). Either 100 μL of DEX (10 μmol·L−1) or 100 μL of BCPs at final concentrations of 10, 20, 40, and 80 μg·mL−1, was added gently to the 48-well plates, to which CAP-treated CRBCs (200 μL per well) had been previously added, and then co-incubated with macrophages for 1 h. After, the plates were washed thoroughly to remove non-engulfed CRBCs, and then macrophages were fixed with 99.9% methanol and marked with Wright-Giemsa staining. Phagocytosis was assessed under light microscopy at 400 × magnification. Calculation of phagocytic index and phagocytic rate was similar: phagocytic rate = number of macrophages that engulfed CRBCs out of 100 macrophages, phagocytic index = number of internalized CRBCs out of 100 macrophages. Phagocytosis assay of FITC-Staphylococcus aureus (FITC- S. aureus) treated with/without CAP The phagocytosis was assayed by detecting ingestion of FITC-S. aureus particles, similar to our previous study with FITC-E. coli [3]. Either 100 μL of DEX (10 μmol·L−1) or 100 μL of BCPs at concentrations equal to the previous 3 tests, with 20 μL of FITC-S.aureus (5×108 FITC-S.aureus·mL−1), were added to the cell cultures (FITC-S.aureus: cells = 50 : 1) and co-incubated with macrophages for 30 min. The 48-well plates were next washed to remove non-engulfed FITCS.aureus, and then cells were fixed with 99.9% methanol and observed under a fluorescence microscope. The fluorescent intracellular area and integral optical density (IOD) were calculated by the software image-J (National Institutes of Health, Bethesda, MD, USA). For the phagocytosis assay of FITC-S.aureus opsonized with CAP, extra 100 μL of CAP was added to the cell cultures before co-incubating. The other steps were exactly the same as mentioned above. Determination of Nitric Oxide (NO) and Cytokines Macrophages were plated at a density of 1 × 106 cells per well into 48-well culture plates and incubated for 24 h with different concentrations of BCPs or BCPs combined with 1 μg·mL−1 of LPS. Next the supernatants were collected and stored at –80 ºC for measurement of NO and cytokines. Determination of nitric oxide (NO) Determination was performed based on the method published by Igor A. Schepetkin [19], in which nitrite ion concentration was used as a NO production indicator and NaNO2 served as a standard substance. Briefly, the supernatant was mixed with an equal volume of Griess reagent and incubated at room temperature for 10 min. Next, the concentration of nitric oxide was measured at 540 nm on a microplate reader. Determination of cytokines Using specific murine ELISA kits (Boatman Corp., Shanghai, China), following the manufacturer’s instructions, levels of TNF-α, IL-6, IL-1β, and IL-12p40 were measured. Intracellular calcium assay The method for measuring [Ca2+]i in macrophages was in

– 891 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

detailed earlier report [20]. Briefly, the RAW264.7 macrophages were scraped from culture flasks and adjusted to a density of 2 × 105 cells·mL−1 in RPMI 1640 medium. Then the cells were plated on 96-culture plates and allowed to adhere for 24 h at 37 ºC in moist air containing 5% CO2. The non-adherent cells were removed by washing twice with RPMI 1640. Fluo-3 AM loading solution was added to the plates to adjust the fluo-3 AM concentration to 1 µmol·L−1, then the plates were incubated at 37 ºC in moist air with 5% CO2 for 45 min. After washing the plates with RPMI 1640 twice, different concentrations of BCPs were added to the plates. 12 min later, Ca2+ fluorescence intensity was measured every 60 s by fluorescence spectrophotometer. The excitation and emission wavelengths were set at 488 nm and 526 nm, respectively. During the experiment, the 96-culture plates were kept constant at 37 ºC. To investigate whether BCPs functions are related to [Ca2+]i, EGTA (ethylene glycol tetraacetic acid) was used to chelate the extracellular calcium. After washing the plates with RPMI 1640 twice, BCPs (80 μg·mL−1) and EGTA were added to the plates, with a final EGTA concentration of 0.5 mmol·L−1. Finally, Ca2+ fluorescence intensity was measured as described above.

Statistical Analysis All the data are expressed as means ± SD. To perform statistical analysis, one-way analysis of variance (ANOVA) was used. Statistical significance was accepted at P < 0.05.

Results Effects of BCPs on chemotaxis of macrophages It has been proven that the complementary system and its products have an important influence on the activation of the innate immune system [21]. Thus, we investigated the effects of BCPs on macrophage chemotaxis, with and without complement-activated product (CAP), C3a, and C5a. Effects of BCPs on chemotaxis As shown in Fig. 1A, chemotactic cell number increased significantly when macrophages were treated with BCPs at 40 and 80 μg·mL−1, compared with the control group (P < 0.05). DEX had an inhibitory effect on it, but did not reach the level of statistical significance. Effects of BCPs on chemotaxis induced by CAP Chemotaxis of macrophages was significantly enhanced by CAP (P < 0.001), compared to the control group. Both BCPs (20 μg·mL−1 and above) and DEX (10 μmol·L−1) significantly suppressed that increase (P < 0.01; Fig. 1B).

Fig. 1 Effects of BCPs on chemotaxis with/without CAP, C5a, and C3a. The data are expressed as means ± SD. n = 3 for each group. A: effect of BCPs on chemotaxis. B: effects of BCPs on CAP-induced chemotaxis. C: effects of BCPs on C5a-induced chemotaxis. D: effects of BCPs on C3a-induced chemotaxis. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group, # P < 0.05, ##P < 0.01, ###P < 0.001 compared with CAP, C5a or C3a stimulated model group, tested by ANOVA

– 892 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

Effects of BCPs on chemotaxis induced by C5a The data shown in Fig. 1C demonstrated that chemotactic cell number increased significantly when cells were treated with C5a (50 ng·mL−1; P < 0.001). BCPs at 40 μg·mL−1 and 80 μg·mL−1, as well as DEX, significantly suppressed the increase of cell number (P < 0.01). Effects of BCPs on chemotaxis induced by C3a Chemotactic cell number increased significantly when macrophages were stimulated with C3a (500 ng·mL−1). However, BCPs and DEX did not decrease chemotactic cell number as induced by C3a (500 ng·mL−1; Fig. 1D). Effects of BCPs on phagocytosis Phagocytosis of pathogens by macrophages initiates the innate immune response. Macrophages have evolved a restricted number of phagocytic receptors to recognize pathogens and opsonized particles, which is critical for the uptake

and degradation of infectious agents in inflammation [22]. Therefore, the effect of BCPs on phagocytosis by macrophage was investigated. Effect of BCPs on phagocytosis of IgG-SRBCs Compared with control group, BCPs increased phagocytosis of IgG-SRBCs (P < 0.01). In contrast, DEX showed a significantly inhibitory effect on phagocytic index and a mild effect on the phagocytic rate (Figs 2A and 2B). Effects of BCPs on phagocytosis of CRBCs BCPs promoted phagocytic index and phagocytic rate of CRBCs, when compared with the control group (P < 0.05), but DEX showed a mild inhibitory effect on it. Both phagocytic rate and phagocytic index also increased in the CAP group. In this case, both BCPs and DEX had significant decreasing effects on phagocytic index (Figs. 3A and 3B), as compared with CAP.

Fig. 2 Effects of BCPs on phagocytosis of IgG-SRBCs. The data are expressed as means ± SD., n = 3 for each group. *P < 0.05, ** P < 0.01, ***P < 0.001 compared with control group, tested by ANOVA

Fig. 3 Effects of BCPs on phagocytosis of CRBCs and FITC- S.aureus. The data are expressed as means ± SD., n = 3 for each group. A&B: Phagocytosis of CRBCs. C&D: Phagocytosis of FITC- S.aureus. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group, #P < 0.05, ##P < 0.01, ###P < 0.001 compared with CAP stimulated model group, tested by ANOVA

– 893 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

Effects of BCPs on phagocytosis of FITC- S.aureus As shown in Figs. 3C and 3D, area of fluorescence increased significantly when macrophages were treated with 80 μg·mL−1 BCPs, compared to the control group. However, BCPs just promoted moderate increase of fluorescence intensity. Fluorescence area and index increased significantly when cells were treated with FITC-S.aureus and CAP. A considerable decrease of both fluorescence area and density was observed in BCPs and DEX groups as compared with the CAP group (P < 0.001). Effects of BCPs on NO and cytokine production Cytokines and inflammatory mediator secreted by macrophage actively intervene in inflammation regulation, such as activating and differentiating T cells, stirring up the adaptive immune response, and also have an important role in the pathogenesis [23]. Suppressing the over secretion of cytokines will be helpful in inflammatory diseases. Thus, we investigated the effect of BCPs on secretion of cytokines and

inflammatory mediator. NO in the medium was significantly increased by BCPs (at 80 μg·mL−1), compared to the control group, as well as by treatment with 1 μg·mL−1 of LPS (Fig 4A). The increase induced by LPS was significantly inhibited by BCPs and DEX. However, the effect of BCPs was much weaker than DEX (P < 0.05). TNF-α, IL-1β, IL-6, IL-12p40, and IL-10 are important inflammation related factors. BCPs increased the production of TNF-α, IL-6, IL-12p40, and IL-10 significantly, as compared with the control group (P < 0.05; Figs. 4B, and 4D-4F). Macrophages generated only a lower level of IL-1β and BCPs had no significantly effect on it (Fig 4C). Compared with the control group, all these cytokines were increased significantly by LPS stimulation (P < 0.001). The elevation of TNF-α, IL-1β, and IL-10 was suppressed significantly by BCPs, while the effects on TNF-α and IL-1β were mild (Figs. 4B-4D). However, IL-6 and IL-12p40 were not influenced significantly by BCPs (Figs. 4E and 4F).

Fig 4. Effects of BCPs on peritoneal macrophages NO and cytokine production. The data are expressed as means ± SD., n = 3 for each group. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control group, #P < 0.05, ##P < 0.01, ###P < 0.001 compared with LPS-stimulated model group, tested by ANOVA

– 894 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

Effects of BCPs on [Ca2+] i in macrophages The levels of [Ca2+]i rose gradually when the cells were exposed to UV radiation continually. 80 μg·m−1 of BCPs inhibited elevation of [Ca2+]i (Fig. 5A). To determine whether BCPs inhibits the influx of intracellular or extracellular Ca2+, extracellular Ca2+ was chelated by EGTA. Compared to both the cells and EGTA groups, the [Ca2+]i level in the BCPs group (at 80 μg·mL−1) was less after 30 min.

Fig. 5 Effects of BCPs on [Ca2+]i of macrophages. A: The effects of BCPs on [Ca2+]i; B: The effects of BCPs on [Ca2+]i when extracellular Ca2+ was chelated by EGTA. The data are expressed as means , n = 3 for each group. *P < 0.05, **P < 0.01, *** P < 0.001 compared with cells group, #P < 0.05, ##P < 0.01, ### P < 0.001 compared with EGTA group, tested by ANOVA

Discussion Bupleurum, a Chinese traditional herb, has been used to treat various diseases for hundreds of years [24]. Polysaccharides fractionated from roots of Bupleurum chinense DC present antioxidant activity and hepatoprotective effect in vivo [25] , and anti-complementary activity in vitro [6]. Considering that tissue macrophages involved in many inflammatory diseases, we hypothesized that BCPs may influence macrophage behavior so as to ameliorate these diseases. Macrophages differentiate from circulating peripheral blood mononuclear cells and are present in virtually all tissues [26]. They play an important role in maintaining homeostasis [27] and have at least three major functions: antigen presentation, phagocytosis and immunomodulation through

production of biologically active molecules. When macrophages are exposed to endogenous danger signals, the responses of macrophages in host defense consist of the following steps: recruitment to the infected site, recognition of pathogens, phagocytosis and destruction of ingested microbes [28]. Macrophage accumulation at local sites is therefore obviously important for host defense against foreign bodies [29]. The recruitment of macrophages to tissue sites is stimulated by a number of factors, including lymphocyte-derived chemotactic factors and complementary factors [30]. Some factors derived from complement system, which is a part of the immune system and enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells. The complement system consists of a large number of distinct plasma proteins that can recognize potential threats and then undergo triggered-enzyme cascade to produce a response of sufficient proportions to neutralize the inflammation [21]. Researches also have proven that complement components C3a and C5a play a critical role in the modulation of immune system, by interacting and activating immune cells via C3a receptor and C5a receptor, respectively. Both are chemoattractant molecules, and allow basophils, macrophages, neutrophils, and lymphocytes recruitment at the inflammatory site [31]. In the present study, we found that BCPs not only promoted chemotaxis of macrophages, but also inhibited enhanced chemotaxis as stimulated by CAP (mixture of complement components after activation), C3a and C5a. Part of the results was consistent with our previous in vivo study. BCPs decreased the total number of inflammatory cells in LPS-induced acute lung injury mice [8]. While our research further suggested that BCPs had a modulatory effect on chemotaxis, BCPs showed better inhibitory effect on chemotaxis induced by C5a than it did for C3a, which might be partly due to the number and affinities of their respective receptors [32]. Another reason for uneven effect may be that C3a is a specific chemotactic mediator which selectively influences eosinophil adhesion, but not transmigration [33]. As an important special phagocyte, macrophages express a broad array of receptors that mediate recognition and internalization when they play their scavenger role in the clearance of foreign materials [34]. In terms of phagocytosis, as related to three kinds of particles studied in our research, Fcγ receptor is involved in the phagocytosis of IgG-SRBC [35], phagocytosis of CRBC has notable positive correlation with expression of toll-like receptor 4 [36], and phagocytosis of FITC- S.aureus is related to the mannose receptor [37]. Our research showed that BCPs alone augmented the phagocytosis of macrophages, while inhibiting it when macrophages were treated with opsonized particles. These results indicated that BCPs might have similar influences on the receptors mentioned above. Cytokines are essential molecules involved in the differentiation, maturation and activation of immune cells, and thus have a significant influence on the inflammatory response [38].

– 895 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

Over-activated macrophages release a great amount of different cytokines which bring about tissue injury [39]. NO is another substance secreted by macrophages, which is a critical mediator modulating a variety of biological functions, and whose excessive production leads to a range of important pathologies [40]. Polysaccharides have been proven to modulate the production of inflammatory mediators [41]. As observed in our research, BCPs showed a modulatory effect on the production of NO and some cytokines. TLR-4 is the ligand of LPS [42], and previous studies have shown that polysaccharides extracted from Bupleurum smithii (BPs) attenuate LPS-stimulated inflammatory response by modulating the TLR-4 signaling pathway in macrophages [3]. The preceding fact reminds us that TLR-4 signaling pathway may be a potential target for BCPs, but it is not the only one. Although Bupleurum chinense DC and Bupleurum smithii belong to the same genus, BCPs and BPs, extracted from these plants respectively, do not have the same actions. BCPs significantly increased production of cytokines, but BPs did not. When macrophages were treated with LPS, BPs had a potent inhibitory effect on TNF-α, IL-6, IL-1β, and IL-12p40 production, while it promoted IL-10 production [3]. Contrastingly, BCPs showed the inhibitory effect on IL-10. IL-10 is a potent anti-inflammatory cytokine [43], which acts at various stages of the immune response in a coordinated way that efficiently restrains the inflammatory response. It affects the functions of monocytes, macrophages or other immune cells, including phagocytosis, presentation of antigen. It also inhibits the production of pro-inflammatory cytokines and chemokines by immune cells such as macrophages. Hence, IL-10 limits the immune response during infection and prevents the immune system damage to the host [44]. In the present study, the secretion of IL-10 was inhibited. The reason might be that BCPs directly suppressed inflammation through down-regulating the chemotaxis and phagocytosis of microorganisms, leading to the decrease of cytokines secretion. Besides, the inhibition of IL-10 secretion might account for the weak action of BCPs on pro-inflammatory cytokine suppression. Overall, BCPs showed a modulatory effect on production of cytokines by macrophages, which is different from the inhibitory effects of BPs. The differences of effects on cytokine production between BCPs and BPs might be related to the different influences on the phenotypic switching mechanism in macrophage polarization [45], which is needed to be explored in the future. Intracellular Ca2+ coordinates a variety of cellular functions, including gene expression, cell cycles, differentiation, migration and tolerance [46]. In the present study, we found that BCPs (80 μg·mL−1) inhibited the elevation of intracellular Ca2+, compared to the control cell group. Furthermore, the effects of BCPs persisted when extracellular Ca2+ was chelated with EGTA. Previous study has shown that UV-irradiation can damage macrophages, leading to increased extracellular Ca2+. An increase in extracellular Ca2+ is accompanied by an

increase in the number of damaged cells [47]. This implied that BCPs might protect macrophages from damage due to over-activation by stimulus, such as LPS, while helping maintain normal macrophage function by inhibiting the over release of intracellular Ca2+. Further study is needed to investigate the potential mechanisms of this phenomenon. By removing or deactivating mediators and inflammatory effector cells, inhibition of inflammation contributes to the repair of damaged tissues [28]. BCPs exposure resulted in enhanced phagocytosis, chemotaxis and secretion of macrophage cytokines, all of which indicated that BCPs might contribute to maintaining the homeostasis under normal conditions. Once the functions of macrophages were significantly enhanced by stimulus, BCPs acted to suppress them, which suggests that BCPs may be able to suppress the over-activation of macrophages, attenuating tissue injury, such as LPS-induced acute lung injury [8]. In general, BCPs showed bilateral regulatory effects on the functions of macrophages. The stimulus substances used in the present study were LPS, chemotactic factors, and opsonized particles, which interacted with various receptors and triggered different signal pathways. BCPs suppressed the actions of all the named stimuli, suggesting that BCPs may modulate those pathways in common. In conclusion, we demonstrated that BCPs modulated cytokine secretion, phagocytosis, and chemotaxis by macrophages under both non-inflammatory and inflammatory conditions. We also found that BCPs had a protective effect on macrophages by inhibiting the release of intracellular Ca2+ under UV-irradiation. The effectual mechanisms of BCPs on macrophages call for further study, yet these findings suggested that BCPs may provide new therapeutic approaches to treating inflammatory diseases.

References [1]

[2]

[3]

[4]

[5]

[6]

[7]

– 896 –

Jiang C, Xiong Q, Gan D, et al. Antioxidant activity and potential hepatoprotective effect of polysaccharides from Cyclina sinensis [J]. Carbohydr Polym, 2013, 91(1): 262-268. Cheng XQ, Li H, Yue XL, et al. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium [J]. J Ethnopharmacol, 2010, 130(2): 363-368. Wu J, Zhang YY, Guo L, et al. Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling [J]. PLoS One, 2013, 8(10): e78051. Wang Z, Li H, Xu H, et al. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice [J]. J Ethnopharmacol, 2009, 124(3): 481-487. Jiang YW, Li H, Zhang YY, et al. Beneficial effect of Bupleurum polysaccharides on autoimmune-prone MRL-lpr mice [J]. Clin Dev Immunol, 2012, 842928. Di H, Zhang Y, Chen D. An anti-complementary polysaccharide from the roots of Bupleurum chinense [J]. Int J Biol Macromol, 2013, 58: 179-185. Xu H, Zhang Y, Zhang J, et al. Isolation and characterization

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

[8]

[9]

[10] [11]

[12] [13] [14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22] [23]

[24]

of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii [J]. Int Immunopharmacol, 2007, 7(2): 175-182. Xie JY, Di HY, Li H, et al. Bupleurum chinense DC polysaccharides attenuates lipopolysaccharide-induced acute lung injury in mice [J]. Phytomedicine, 2012, 19(2): 130-137. Cheng XQ, Song LJ, Li H, et al. Beneficial effect of the polysaccharides from Bupleurum smithii var. parvifolium on "two-hit" acute lung injury in rats [J]. Inflammation, 2012, 35(5): 1715-1722. Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis [J]. J Rheumatol, 1999, 26(3): 717-719. Burmester GR, Stuhlmuller B, Keyszer G, et al. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? [J]. Arthritis Rheum, 1997, 40(1): 5-18. Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses [J]. Genes Cells, 2001, 6(9): 733-742. Mandeville JT, Maxfield FR. Calcium and signal transduction in granulocytes [J]. Curr Opin Hematol, 1996, 3(1): 63-70. Azenabor AA, Kennedy P, York J. Free intracellular Ca2+ regulates bacterial lipopolysaccharide induction of iNOS in human macrophages [J]. Immunobiology, 2009, 214(2): 143-152. Chen BC, Hsieh SL , Lin WW. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages [J]. J Leukoc Biol, 2001, 69(2): 280-288. Ye Y, Huang X, Zhang Y , et al. Calcium influx blocked by SK&F 96365 modulates the LPS plus IFN-gamma-induced inflammatory response in murine peritoneal macrophages [J]. Int Immunopharmacol, 2012, 12(2): 384-393. El-Mahmoudy A, Matsuyama H, Borgan MA, et al. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages [J]. Intern Immunopharmacol, 2002, 2(11): 1603-1611. Wang XQ, Yu J, Luo XZ, et al. The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis [J]. Mole Endocrinol, 2010, 45(5): 291-299. Schepetkin IA, Faulkner CL, Nelson-Overton LK, et al. Macrophage immunomodulatory activity of polysaccharides isolated from Juniperus scopolorum [J]. Int Immunopharmacol, 2005, 5(13-14): 1783-1799. Brown DM, Hutchison L, Donaldson K, et al. The effects of PM10 particles and oxidative stress on macrophages and lung epithelial cells: modulating effects of calcium-signaling antagonists [J]. Am J Physiol Lung Cell Mol Physiol, 2007, 292(6): L1444-1451. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses [J]. Cell Res, 2010, 20(1): 34-50. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages [J]. Annu Rev Immunol, 1999, 17: 593-623. Moldoveanu AC, Diculescu M, Braticevici CF. Cytokines in inflammatory bowel disease [J]. Rom J Intern Med, 2015, 53(2): 118-127. Wang BJ, Liu CT, Tseng CY, et al. Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO(2) on CCl(4)-induced liver damage [J]. Food Chem Toxicol, 2004, 42(4): 609-617.

[25] Zhao W, Li JJ, Yue SQ, et al. Antioxidant activity and hepatoprotective effect of a polysaccharide from Bei Chaihu (Bupleurum chinense DC) [J]. Carbohydr Polym, 2012, 89(2): 448-452. [26] Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation [J]. Nat Rev Immunol, 2008, 8(12): 958969. [27] Gordon S. The macrophage as therapeutic target [M]. Springer, 2003. [28] Fujiwara N, Kobayashi K. Macrophages in inflammation [J]. Curr Drug Targets Inflamm Allergy, 2005, 4(3): 281-286. [29] Snyderman R, Pike MC, McCarley D, et al. Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity [J]. Infect Immun, 1975, 11(3): 488-492. [30] Laskin DL, Laskin JD, Weinstein IB, et al. Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters [J]. Cancer Res, 1981, 41(5): 1923-1928. [31] Merle NS, Noe R, Halbwachs-Mecarelli L, et al. Complement System Part II: Role in Immunity [J]. Front Immunol, 2015, 6: 257. [32] Ehrengruber MU, Geiser T, Deranleau DA. Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst [J]. FEBS Lett, 1994, 346(2-3): 181-184. [33] DiScipio RG, Daffern PJ, Jagels MA, et al. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo [J]. J Immunol, 1999, 162(2): 1127-1136. [34] Brock TG, Serezani CH, Carstens JK, et al. Effects of prostaglandin E2 on the subcellular localization of Epac-1 and Rap1 proteins during Fcgamma-receptor-mediated phagocytosis in alveolar macrophages [J]. Exp Cell Res, 2008, 314(2): 255-263. [35] Song EK, Lee YR, Yu HN, et al. Extracellular NAD is a regulator for FcgammaR-mediated phagocytosis in murine macrophages [J]. Biochem Biophys Res Commun, 2008, 367(1): 156161. [36] Li ZF, Zhang Y, Gao J, et al. Expression and significance of Toll-like receptor 4 of splenic macrophage in patients with hypersplenism due to portal hypertension [J]. Zhonghua Yi Xue Za Zhi, 2004, 84(13): 1088-1091. [37] Rajagopalan R, Nyaundi T, Salvi VP, et al. Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement [J]. Mol Immunol, 2010, 47(15): 2505-2514. [38] Aringer M, Smolen JS. Cytokine expression in lupus kidneys [J]. Lupus, 2005, 14(1): 13-18. [39] Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury [J]. Annu Rev Pharmacol Toxicol, 1995, 35: 655-677. [40] Kim KS, Cho HS, Lee SD, et al. Inhibitory effect of Buthus martensi Karsch extracts on interleukin-1beta-induced expression of nitric oxide (NO) synthase and production of NO in human chondrocytes and LPS-induced NO and prostaglandin E2 production in mouse peritoneal macrophages [J]. Toxicol In Vitro, 2005, 19(6): 757-769. [41] Lee JY, Kim YJ, Kim HJ, et al. Immunostimulatory effect of laminarin on RAW 264.7 mouse macrophages [J]. Molecules,

– 897 –

ZHANG Zhi-De, et al. / Chin J Nat Med, 2017, 15(12): 889898

2012, 17(5): 5404-5411. [42] Lorne E, Zhao X, Zmijewski JW, et al. Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2and 4-induced neutrophil activation and acute lung injury [J]. Am J Respir Cell Mol Biol, 2009, 41(2): 237-245. [43] Hutchins AP, Diez D, Miranda-Saavedra D. The IL-10/STAT3mediated anti-inflammatory response: recent developments and future challenges [J]. Brief Funct Genomics, 2013, 12(6): 489498. [44] Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines [J]. Nat

Immunol, 2012, 13(10): 925-931. [45] Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization [J]. Trends Immunol, 2004, 25(12): 677-686. [46] Braun AP, Schulman H. The multifunctional calcium/ calmodulin-dependent protein kinase: from form to function [J]. Annu Rev Physiol, 1995, 57: 417-445. [47] Pirutin SK, Turovetskii VB, Pirutina OV, et al. Influence of Ca2+ ions on UV-induced damage to mice peritoneal macrophage plasma membranes [J]. Radiats Biol Radioecol, 2004, 44(4): 438-441.

Cite this article as: ZHANG Zhi-De, LI Hong, WAN Fen, SU Xiao-Yu, LU Yan, CHEN Dao-Feng, ZHANG Yun-Yi. Polysaccharides extracted from the roots of Bupleurum chinense DC modulates macrophage functions [J]. Chin J Nat Med, 2017, 15(12): 889-898.

Zhang Yun-Yi, Associate Professor, Department of Pharmacology, School of Pharmacy, Fudan University. The research work of Prof. ZHANG is on immunopharmacology. He has been working on pharmacology effects of polysaccharide extracted from Traditional Chinese Medicine. Studies revealed that polysaccharides might enhance the function of macrophage but suppress it when cells were over activated. Resently, he focus on the use of polysacchrides in the treatment of influenza and lung injury. Papers about these researches have been published.

– 898 –